share_log

Virpax Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Herman Gary L

SEC ·  Jul 10 04:06

Summary by Futu AI

Gary L. Herman, a director and 10% owner of Virpax Pharmaceuticals, filed an initial statement of beneficial ownership with the SEC on July 5, 2024, as per Form 3 requirements. The filing, which is a routine disclosure for individuals in such positions, indicates that currently, no securities are beneficially owned by Herman. The form was signed by attorney-in-fact Vinay Shah on behalf of Gary Herman on July 9, 2024. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 and is a standard procedure for corporate insiders to report their securities holdings.
Gary L. Herman, a director and 10% owner of Virpax Pharmaceuticals, filed an initial statement of beneficial ownership with the SEC on July 5, 2024, as per Form 3 requirements. The filing, which is a routine disclosure for individuals in such positions, indicates that currently, no securities are beneficially owned by Herman. The form was signed by attorney-in-fact Vinay Shah on behalf of Gary Herman on July 9, 2024. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 and is a standard procedure for corporate insiders to report their securities holdings.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated